National Vision Holdings, Inc. Finance Lease, Right-of-Use Asset, Amortization
National Vision Holdings, Inc. (EYE) reported Finance Lease, Right-of-Use Asset, Amortization of $2.19 million for the 12-month period ending 2026-01-03, per its 10-K filed 2026-03-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2026-03-04
- National Vision Holdings, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2024-12-28 was $565.00K, a 5.41% increase year-over-year.
- National Vision Holdings, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2024-09-28 was $564.00K, a 27.23% decline year-over-year.
- National Vision Holdings, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2024-06-29 was $582.00K, a 34.90% decline year-over-year.
- National Vision Holdings, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2024-03-30 was $659.00K, a 23.10% decline year-over-year.
- National Vision Holdings, Inc. finance lease, right-of-use asset, amortization for fiscal 2026 was $2.19M, a 7.43% decline from fiscal 2024.
- National Vision Holdings, Inc. finance lease, right-of-use asset, amortization for fiscal 2024 was $2.37M, a 22.57% decline from fiscal 2023.
- National Vision Holdings, Inc. finance lease, right-of-use asset, amortization for fiscal 2023 was $3.06M, a 26.15% decline from fiscal 2022.
- National Vision Holdings, Inc. finance lease, right-of-use asset, amortization for fiscal 2022 was $4.14M, a 7.08% decline from fiscal 2022.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 3 month as first filed | Finance Lease, Right-of-Use Asset, Amortization 6 month | Finance Lease, Right-of-Use Asset, Amortization 9 month | Finance Lease, Right-of-Use Asset, Amortization 12 month |
|---|---|---|---|---|---|
| 2026-01-03 | $2.19M 10-K · filed 2026-03-04 | ||||
| 2024-12-28 | $565.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $1.13M derived: sum of 2 quarters · filed 2026-03-04 | $1.71M derived: sum of 3 quarters · filed 2026-03-04 | $2.37M 10-K · filed 2026-03-04 | |
| 2024-09-28 | $564.00K 10-Q · filed 2024-11-06 | $1.15M derived: sum of 2 quarters · filed 2024-11-06 | $1.80M 10-Q · filed 2024-11-06 | $2.34M derived: sum of 4 quarters · filed 2026-03-04 | |
| 2024-06-29 | $582.00K 10-Q · filed 2024-08-07 | $1.24M 10-Q · filed 2024-08-07 | $1.78M derived: sum of 3 quarters · filed 2026-03-04 | $2.55M derived: sum of 4 quarters · filed 2026-03-04 | |
| 2024-03-30 | $659.00K 10-Q · filed 2024-05-08 | $1.20M derived: sum of 2 quarters · filed 2026-03-04 | $1.97M derived: sum of 3 quarters · filed 2026-03-04 | $2.86M derived: sum of 4 quarters · filed 2026-03-04 | |
| 2023-12-30 | $536.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $1.31M derived: sum of 2 quarters · filed 2026-03-04 | $2.21M derived: sum of 3 quarters · filed 2026-03-04 | $3.06M 10-K · filed 2026-03-04 | |
| 2023-09-30 | $775.00K 10-Q · filed 2024-11-06 | $1.67M derived: sum of 2 quarters · filed 2024-11-06 | $2.52M 10-Q · filed 2024-11-06 | $3.48M derived: sum of 4 quarters · filed 2025-02-26 | |
| 2023-07-01 | $894.00K 10-Q · filed 2024-08-07 | $893.00K 10-Q · filed 2023-08-10 | $1.75M 10-Q · filed 2024-08-07 | $2.71M derived: sum of 3 quarters · filed 2025-02-26 | $3.73M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-04-01 | $857.00K 10-Q · filed 2024-05-08 | $1.82M derived: sum of 2 quarters · filed 2025-02-26 | $2.84M derived: sum of 3 quarters · filed 2025-02-26 | $3.92M derived: sum of 4 quarters · filed 2025-02-26 | |
| 2022-12-31 | $959.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $1.98M derived: sum of 2 quarters · filed 2025-02-26 | $3.06M derived: sum of 3 quarters · filed 2025-02-26 | $4.14M 10-K · filed 2025-02-26 | |
| 2022-10-01 | $1.02M 10-Q · filed 2023-11-09 | $2.10M derived: sum of 2 quarters · filed 2023-11-09 | $3.19M 10-Q · filed 2023-11-09 | $4.30M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-07-02 | $1.08M 10-Q · filed 2023-08-10 | $2.16M 10-Q · filed 2023-08-10 | $3.27M derived: sum of 3 quarters · filed 2024-02-27 | $4.39M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-04-02 | $1.08M 10-Q · filed 2023-05-11 | $2.19M derived: sum of 2 quarters · filed 2024-02-27 | $3.31M derived: sum of 3 quarters · filed 2024-02-27 | $4.42M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-01-01 | $1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $2.23M derived: sum of 2 quarters · filed 2024-02-27 | $3.34M derived: sum of 3 quarters · filed 2024-02-27 | $4.46M 10-K · filed 2024-02-27 | |
| 2021-10-02 | $1.11M 10-Q · filed 2022-11-10 | $2.23M derived: sum of 2 quarters · filed 2022-11-10 | $3.35M 10-Q · filed 2022-11-10 | $4.49M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-07-03 | $1.11M 10-Q · filed 2022-08-11 | $2.24M 10-Q · filed 2022-08-11 | $3.37M derived: sum of 3 quarters · filed 2023-03-01 | $4.52M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-04-03 | $1.12M 10-Q · filed 2022-05-10 | $2.26M derived: sum of 2 quarters · filed 2023-03-01 | $3.40M derived: sum of 3 quarters · filed 2023-03-01 | $4.53M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-01-02 | $1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $2.28M derived: sum of 2 quarters · filed 2023-03-01 | $3.40M derived: sum of 3 quarters · filed 2023-03-01 | $4.56M 10-K · filed 2023-03-01 | |
| 2020-09-26 | $1.14M 10-Q · filed 2021-11-10 | $2.27M derived: sum of 2 quarters · filed 2021-11-10 | $3.42M 10-Q · filed 2021-11-10 | $4.61M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-06-27 | $1.13M 10-Q · filed 2021-08-12 | $2.28M 10-Q · filed 2021-08-12 | $3.47M derived: sum of 3 quarters · filed 2022-02-28 | $4.64M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-03-28 | $1.16M 10-Q · filed 2021-05-13 | $2.34M derived: sum of 2 quarters · filed 2022-02-28 | $3.52M derived: sum of 3 quarters · filed 2022-02-28 | $4.60M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2019-12-28 | $1.19M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $2.36M derived: sum of 2 quarters · filed 2022-02-28 | $3.44M derived: sum of 3 quarters · filed 2022-02-28 | $4.42M 10-K · filed 2022-02-28 | |
| 2019-09-28 | $1.18M 10-Q · filed 2020-11-05 | $2.25M derived: sum of 2 quarters · filed 2020-11-05 | $3.23M 10-Q · filed 2020-11-05 | ||
| 2019-06-29 | $1.08M 10-Q · filed 2020-08-06 | $2.06M 10-Q · filed 2020-08-06 | |||
| 2019-03-30 | $978.00K 10-Q · filed 2020-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |